Search Results - "de Wilt, L.H.A.M"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    TRAIL receptor targeting therapies for non-small cell lung cancer: Current status and perspectives by Stegehuis, J.H, de Wilt, L.H.A.M, de Vries, E.G.E, Groen, H.J, de Jong, S, Kruyt, F.A.E

    Published in Drug resistance updates (01-02-2010)
    “…Abstract Non-small cell lung cancer (NSCLC) is a common and often fatal malignancy, diagnosed at an advanced stage in more than half of the cases…”
    Get full text
    Journal Article
  2. 2

    Bortezomib and TRAIL: A perfect match for apoptotic elimination of tumour cells? by de Wilt, L.H.A.M, Kroon, J, Jansen, G, de Jong, S, Peters, G.J, Kruyt, F.A.E

    Published in Critical reviews in oncology/hematology (01-03-2013)
    “…Abstract Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a cytokine that selectively eradicates tumour cells via specific cell surface…”
    Get full text
    Journal Article